\-\ Texto\\:\\ \ \(0\)\
\-\ palpable\\ midline\\ mass\ \(1\)\
\-\ marginal\\ excision\\,\\ radiotherapy\\,\\ and\\ chemotherpay\\ \\(doxyrubicin\\ and\\ cyclophosphamide\\)\ \(0\)\
\-\ patient\\ developed\\ metastases\\ to\\ the\\ liver\\ within\\ 2\\ years\\ of\\ primary\\ treatment\\.\ \(0\)\
\-\ axial\\ and\\ reformatted\\ sagittal\\ ct\\ scans\\ of\\ the\\ abdomen\\ after\\ oral\\ and\\ intraveous\\ contrast\\ show\\ a\\ large\\ extraluminal\\ mass\\ with\\ areas\\ of\\ low\\-attenuation\\ mass\\ with\\ nodularity\\ and\\ large\\ areas\\ of\\ necrosis\\ and\\ hemorrhage\\.\\ on\\ some\\ images\\,\\ the\\ mass\\ is\\ adherent\\ to\\ the\\ stomach\\ and\\ displaces\\ surrounding\\ viscera\\.\ \(0\)\
\-\ synovial\\ sarcoma\\-biphasic\ \(0\)\
\-\ synovial\\ sarcoma\\,\\ leiomyosarcoma\\,metastatic\\ disease\\,\\ malignant\\ fibrous\\ histiocytoma\\ sarcoma\\,\\ rhabdomyosarcoma\\,\\ liposarcoma\\,\\ burkitt\\ lymphoma\ \(0\)\
\-\ unfortunately\\ this\\ patient\\ developed\\ an\\ uncommon\\ soft\\ tissue\\ neoplasm\\ in\\ an\\ atypical\\ location\\,\\ which\\ progressed\\ despite\\ optimal\\ surgical\\ and\\ medical\\ management\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ synovial\\:\\ 0\\.0803851707957107\ \(0\)\
\-\ chemotherpay\\:\\ 0\\.07225834773743031\ \(0\)\
\-\ intraveous\\:\\ 0\\.07225834773743031\ \(0\)\
\-\ sarcoma\\-biphasic\\:\\ 0\\.07225834773743031\ \(0\)\
\-\ doxyrubicin\\:\\ 0\\.06325332897785564\ \(0\)\
\-\ sarcoma\\:\\ 0\\.062375133276561356\ \(0\)\
\-\ low\\-attenuation\\:\\ 0\\.05424831021828097\ \(0\)\
\-\ developed\\:\\ 0\\.05393549975138876\ \(0\)\
\-\ burkitt\\:\\ 0\\.05338469943420043\ \(0\)\
\-\ viscera\\:\\ 0\\.05260346845219777\ \(0\)\
\-\ extraluminal\\:\\ 0\\.05123417267627017\ \(0\)\
\-\ cyclophosphamide\\:\\ 0\\.05062673028156754\ \(0\)\
\-\ optimal\\:\\ 0\\.05062673028156754\ \(0\)\
\-\ adherent\\:\\ 0\\.04953221066989112\ \(0\)\
\-\ reformatted\\:\\ 0\\.048566775951396184\ \(0\)\
\-\ areas\\:\\ 0\\.04713683887288634\ \(0\)\
\-\ leiomyosarcoma\\:\\ 0\\.04620872617720125\ \(0\)\
\-\ histiocytoma\\:\\ 0\\.04620872617720125\ \(0\)\
\-\ marginal\\:\\ 0\\.04587411966474014\ \(0\)\
\-\ nodularity\\:\\ 0\\.04411091163509305\ \(0\)\
\-\ displaces\\:\\ 0\\.043598449692623095\ \(0\)\
\-\ radiotherapy\\:\\ 0\\.042660659928871095\ \(0\)\
\-\ liposarcoma\\:\\ 0\\.04222915391669551\ \(0\)\
\-\ progressed\\:\\ 0\\.04052719191031646\ \(0\)\
\-\ unfortunately\\:\\ 0\\.04019258539785535\ \(0\)\
\-\ rhabdomyosarcoma\\:\\ 0\\.03941135441585268\ \(0\)\
\-\ mass\\:\\ 0\\.038965934654018514\ \(0\)\
\-\ uncommon\\:\\ 0\\.0342687658666956\ \(0\)\
\-\ scans\\:\\ 0\\.0326166927624182\ \(0\)\
\-\ despite\\:\\ 0\\.03255189620908121\ \(0\)\
\-\ stomach\\:\\ 0\\.030971850996334996\ \(0\)\
\-\ large\\:\\ 0\\.0306318431447718\ \(0\)\
\-\ atypical\\:\\ 0\\.03035680848860619\ \(0\)\
\-\ metastases\\:\\ 0\\.029924036475762167\ \(0\)\
\-\ oral\\:\\ 0\\.029512972675061578\ \(0\)\
\-\ excision\\:\\ 0\\.028747956775125354\ \(0\)\
\-\ fibrous\\:\\ 0\\.028313329985713714\ \(0\)\
\-\ sagittal\\:\\ 0\\.027937267643494915\ \(0\)\
\-\ necrosis\\:\\ 0\\.027648366503645123\ \(0\)\
\-\ midline\\:\\ 0\\.027099426945397714\ \(0\)\
\-\ management\\:\\ 0\\.02643058560209542\ \(0\)\
\-\ malignant\\:\\ 0\\.025316972757207387\ \(0\)\
\-\ palpable\\:\\ 0\\.02482476264426058\ \(0\)\
\-\ location\\:\\ 0\\.024432030220523714\ \(0\)\
\-\ liver\\:\\ 0\\.024149356646169868\ \(0\)\
\-\ neoplasm\\:\\ 0\\.02385374242550761\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.023313578558819964\ \(0\)\
\-\ surrounding\\:\\ 0\\.023025944789875127\ \(0\)\
\-\ \\,\\:\\ 0\\.022189349632564536\ \(0\)\
\-\ medical\\:\\ 0\\.02155171967267217\ \(0\)\
\-\ show\\:\\ 0\\.021501278151570706\ \(0\)\
\-\ some\\:\\ 0\\.02126990372021934\ \(0\)\
\-\ primary\\:\\ 0\\.020749051335210628\ \(0\)\
\-\ abdomen\\:\\ 0\\.020749051335210628\ \(0\)\
\-\ years\\:\\ 0\\.02056756669687281\ \(0\)\
\-\ lymphoma\\:\\ 0\\.02001802159335644\ \(0\)\
\-\ axial\\:\\ 0\\.019990094066130094\ \(0\)\
\-\ an\\:\\ 0\\.019371555152208685\ \(0\)\
\-\ metastatic\\:\\ 0\\.017632044291935167\ \(0\)\
\-\ soft\\:\\ 0\\.017056776754045492\ \(0\)\
\-\ tissue\\:\\ 0\\.016601813020103228\ \(0\)\
\-\ contrast\\:\\ 0\\.015678489236130373\ \(0\)\
\-\ 2\\:\\ 0\\.015082823741889724\ \(0\)\
\-\ surgical\\:\\ 0\\.014723129264356177\ \(0\)\
\-\ after\\:\\ 0\\.014491813136141004\ \(0\)\
\-\ treatment\\:\\ 0\\.014177188193449894\ \(0\)\
\-\ patient\\:\\ 0\\.014042490670760459\ \(0\)\
\-\ images\\:\\ 0\\.013436589278273394\ \(0\)\
\-\ within\\:\\ 0\\.01336173285562362\ \(0\)\
\-\ which\\:\\ 0\\.013074955633135646\ \(0\)\
\-\ and\\:\\ 0\\.011803869228342194\ \(0\)\
\-\ disease\\:\\ 0\\.011448668370620526\ \(0\)\
\-\ ct\\:\\ 0\\.009797570929442976\ \(0\)\
\-\ this\\:\\ 0\\.007878173879624042\ \(0\)\
\-\ to\\:\\ 0\\.007001116531852234\ \(0\)\
\-\ on\\:\\ 0\\.005933532888241214\ \(0\)\
\-\ \\(\\:\\ 0\\.005920997756097218\ \(0\)\
\-\ \\)\\:\\ 0\\.005848669607486107\ \(0\)\
\-\ is\\:\\ 0\\.004608940806432178\ \(0\)\
\-\ the\\:\\ 0\\.004532763432905764\ \(0\)\
\-\ of\\:\\ 0\\.0038197967474750305\ \(0\)\
\-\ in\\:\\ 0\\.003454075656887336\ \(0\)\
\-\ a\\:\\ 0\\.0032508180476934533\ \(0\)\
\-\ with\\:\\ 0\\.0019181012473752416\ \(0\)\
\-\ \\.\\:\\ 0\\.0011639192163064352\ \(0\)\
